Table 4.
Drug | Severity and duration |
---|---|
Chemotherapeutic drugs commonly associated with severe nausea and vomiting | |
Nitrogen mustard (mustine hydrochloride; mechlorethamine hydrochloride USP) | Occurs in virtually all patients. May be severe, but usually subsides within 24 h |
Chloroethyl nitrosoureas, streptozotoci (streptozocin) | Variable, but may be severe. Occurs in nearly all patients. Tolerance improves with each successive dose given on a 5-day schedule |
Cis-platinum (cisplatin) | May be very severe. Tolerance improves with intravenous hydration and continuous 5-day infusion. Nausea may persist for several days |
Imidazole carboxamide (DTIC; dacarbazine) | Occurs in virtually all patients. Tolerance improves with each successive dose given on a 5-day schedule |
Chemotherapeutic drugs commonly associated with mucositis | |
Methotrexate | May be quite severe with prolonged infusions or if renal function is compromised. Severity is enhanced by irradiation. May be prevented with administration of adequate citrovorum rescue factor (folinic acid; leucovorin) |
5-Fluorouracil (fluorouracil USP) | Severity increase with higher doses, frequency of cycles, and arterial infusions |
Actinomycin D (dactinomycin USP) | Very common; may prevent oral alimentation. Severity enhanced by irradiation |
Adriamycin (doxorubicin) | May be severe and ulcerative. Increased in presence of liver disease. Severity enhanced by irradiation |
Bleomycin | May be severe and ulcerative |
Vinblastine | Frequently ulcerative |
Source: [81]